A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury (Q46869499)
scientific article published in December 2005
Language:
(P31) (Q13442814)
(P304) 1444-1455
(P407) (Q1860)
(P433) 12
(P478) 22
(P577) Thursday, December 1, 2005
(P921) (Q269829)
(P1433) (Q15716774)
(P1476) "A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury" (language: en)
(P2093) Anthony Marmarou
Martine Guy
Laine Murphey
Francis Roy
Laure Layani
Jean-Philippe Combal
Claude Marquer
American Brain Injury Consortium
other details
description scientific article published in December 2005

External Links